AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2024
Mar 12, 2024
30786_dirs_2024-03-12_110da6ca-5d97-4b3c-b3d8-734b8eee8be7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2024-03-08
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-08 | Non-Qualified Stock Option (right to buy) | $343.76 | A | 14137 | Acquired | 2034-03-08 | Bio-Rad A Common Stock (14137) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 432920 | Direct |
| Bio-Rad B Common Stock | 361409 | Direct |
| Bio-Rad B Common Stock | 12949 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of these shares.
F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13